NextCure Management

Management criteria checks 3/4

NextCure's CEO is Michael Richman, appointed in Oct 2015, has a tenure of 8.42 years. total yearly compensation is $1.72M, comprised of 31.9% salary and 68.1% bonuses, including company stock and options. directly owns 1.42% of the company’s shares, worth $788.69K. The average tenure of the management team and the board of directors is 3.2 years and 4.9 years respectively.

Key information

Michael Richman

Chief executive officer

US$1.7m

Total compensation

CEO salary percentage31.9%
CEO tenure8.4yrs
CEO ownership1.4%
Management average tenure3.2yrs
Board average tenure4.9yrs

Recent management updates

Recent updates

We're Keeping An Eye On NextCure's (NASDAQ:NXTC) Cash Burn Rate

Mar 23
We're Keeping An Eye On NextCure's (NASDAQ:NXTC) Cash Burn Rate

We're Keeping An Eye On NextCure's (NASDAQ:NXTC) Cash Burn Rate

Dec 09
We're Keeping An Eye On NextCure's (NASDAQ:NXTC) Cash Burn Rate

Will NextCure (NASDAQ:NXTC) Spend Its Cash Wisely?

Aug 23
Will NextCure (NASDAQ:NXTC) Spend Its Cash Wisely?

Is NextCure (NASDAQ:NXTC) In A Good Position To Deliver On Growth Plans?

May 10
Is NextCure (NASDAQ:NXTC) In A Good Position To Deliver On Growth Plans?

We're Keeping An Eye On NextCure's (NASDAQ:NXTC) Cash Burn Rate

Nov 22
We're Keeping An Eye On NextCure's (NASDAQ:NXTC) Cash Burn Rate

Estimating The Intrinsic Value Of NextCure, Inc. (NASDAQ:NXTC)

Aug 09
Estimating The Intrinsic Value Of NextCure, Inc. (NASDAQ:NXTC)

NextCure GAAP EPS of -$0.59

Aug 04

We're Not Very Worried About NextCure's (NASDAQ:NXTC) Cash Burn Rate

May 02
We're Not Very Worried About NextCure's (NASDAQ:NXTC) Cash Burn Rate

NextCure: Large Upside With Downside Protected By Cash Pile

Sep 29

NextCure (NXTC) Presents at 7th Annual Truist Securities Life Sciences Summit - Slideshow

May 10

NextCure EPS misses by $0.01

May 06

Here's What NextCure, Inc.'s (NASDAQ:NXTC) Shareholder Ownership Structure Looks Like

Feb 12
Here's What NextCure, Inc.'s (NASDAQ:NXTC) Shareholder Ownership Structure Looks Like

NextCure's (NASDAQ:NXTC) Shareholders Are Down 80% On Their Shares

Jan 08
NextCure's (NASDAQ:NXTC) Shareholders Are Down 80% On Their Shares

NextCure provides update on NC318 clinical program

Dec 17

CEO Compensation Analysis

How has Michael Richman's remuneration changed compared to NextCure's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

-US$63m

Sep 30 2023n/an/a

-US$66m

Jun 30 2023n/an/a

-US$70m

Mar 31 2023n/an/a

-US$70m

Dec 31 2022US$2mUS$549k

-US$75m

Sep 30 2022n/an/a

-US$74m

Jun 30 2022n/an/a

-US$73m

Mar 31 2022n/an/a

-US$73m

Dec 31 2021US$3mUS$529k

-US$69m

Sep 30 2021n/an/a

-US$68m

Jun 30 2021n/an/a

-US$66m

Mar 31 2021n/an/a

-US$63m

Dec 31 2020US$6mUS$491k

-US$37m

Sep 30 2020n/an/a

-US$32m

Jun 30 2020n/an/a

-US$24m

Mar 31 2020n/an/a

-US$18m

Dec 31 2019US$626kUS$419k

-US$34m

Sep 30 2019n/an/a

-US$30m

Jun 30 2019n/an/a

-US$27m

Mar 31 2019n/an/a

-US$24m

Dec 31 2018US$3mUS$383k

-US$23m

Compensation vs Market: Michael's total compensation ($USD1.72M) is above average for companies of similar size in the US market ($USD661.05K).

Compensation vs Earnings: Michael's compensation has been consistent with company performance over the past year.


CEO

Michael Richman (62 yo)

8.4yrs

Tenure

US$1,724,186

Compensation

Mr. Michael S. Richman, MSBA, Co-founded NextCure, Inc. since 2015 and has been its Chief Executive Officer, President & Director since July 2015. Mr. Richman served as the Chief Executive Officer and Pres...


Leadership Team

NamePositionTenureCompensationOwnership
Michael Richman
Co-Founder8.4yrsUS$1.72m1.42%
$ 788.7k
Solomon Langermann
Chief Scientific Officer5.3yrsUS$990.52k0.13%
$ 74.3k
Han Myint
Chief Medical Officer3.2yrsUS$953.32k0%
$ 0
Lieping Chen
Co-Founder & Chairman of Scientific Advisory Board9.2yrsno datano data
Steven Cobourn
Chief Financial Officer6.2yrsUS$1.01mno data
Timothy Mayer
Chief Operating Officer4.4yrsno datano data
Kevin Shaw
General Counsel1.8yrsno datano data
Stacy Rollinger
Vice President of Human Resourcesless than a yearno datano data
Sourav Kundu
Senior Vice President of Development & Manufacturing2.7yrsno datano data
Sebastien Maloveste
Senior Vice President of Business Developmentless than a yearno datano data
Udayan Guha
Senior Vice President of Clinical & Translational Developmentless than a yearno datano data

3.2yrs

Average Tenure

62.5yo

Average Age

Experienced Management: NXTC's management team is considered experienced (3.2 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Michael Richman
Co-Founder8.4yrsUS$1.72m1.42%
$ 788.7k
Lieping Chen
Co-Founder & Chairman of Scientific Advisory Boardno datano datano data
Elaine Jones
Independent Director8.3yrsUS$94.17k0%
$ 0
Mario Sznol
Member of Scientific Advisory Boardno datano datano data
David Kabakoff
Independent Chairman of the Board8.3yrsUS$122.67k0.22%
$ 123.9k
Stephen Webster
Independent Director4.9yrsUS$101.17k0%
$ 0
Chau Khuong
Independent Director8.3yrsUS$96.17k0%
$ 0
Ellen Feigal
Independent Director2.4yrsUS$91.17k0%
$ 0
Stephen Miller
Member of Scientific Advisory Boardno datano datano data
John Houston
Independent Director3.5yrsUS$91.17k0%
$ 0
Ursula Matulonis
Member of Scientific Advisory Board2.4yrsno datano data
Anne Borgman-Hagey
Independent Director2.4yrsUS$90.17k0%
$ 0

4.9yrs

Average Tenure

64yo

Average Age

Experienced Board: NXTC's board of directors are considered experienced (4.9 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.